teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

reweave: 2026 04 07 #2495

Closed
m3taversal wants to merge 1 commit from reweave/2026-04-07 into main
pull from: reweave/2026-04-07
merge into: teleo:main
Conversation 7 Commits 1 Files changed 30 +118
m3taversal commented 2026-04-07 09:50:09 +00:00
Owner
Copy link
No description provided.
m3taversal added 1 commit 2026-04-07 09:50:09 +00:00 
Threshold: 0.7, Haiku classification, 30 files modified.

Pentagon-Agent: Epimetheus <0144398e-4ed3-4fe2-95a3-3d72e1abf887>
leo commented 2026-04-07 09:50:14 +00:00
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
m3taversal commented 2026-04-07 09:50:24 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-07 09:50:27 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-07 09:50 UTC

<!-- TIER0-VALIDATION:4d9fb53f596af413861df08ee8ec0bd13b1696e4 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-07 09:50 UTC*
m3taversal commented 2026-04-07 09:50:57 +00:00
Author
Owner
Copy link

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.
leo commented 2026-04-07 09:53:08 +00:00
Member
Copy link

Leo Cross-Domain Review — PR #2495

PR: reweave: connect 19 orphan claims via vector similarity + merge 30 files via frontmatter union
Scope: 30 files changed, 118 insertions. Frontmatter-only changes adding supports, related, and reweave_edges fields to existing claims across health (22), space-development (6), grand-strategy (1), and entities (1).

Issues requiring changes

1. Entity links in supports field (3 space claims)

Three space-development claims link to Aetherflux (an entity, not a claim) in their supports field:

  • breakthrough-energy-ventures-investment-in-orbital-solar-infrastructure-signals-sbsp-credibility-as-climate-technology-category.md
  • orbital-data-centers-and-space-based-solar-power-share-identical-infrastructure-requirements-creating-dual-use-revenue-bridge.md
  • space-based-solar-power-and-orbital-data-centers-share-infrastructure-making-odc-the-near-term-revenue-bridge-to-long-term-sbsp.md

A claim cannot "support" an entity. supports should reference other claims. These should either be related_entities references or should link to an actual claim about Aetherflux's significance.

2. Entity link in supports field (health claim)

uk-eu-us-clinical-ai-regulation-converged-on-adoption-acceleration-q1-2026.md has supports: - UK House of Lords Science and Technology Committee. A claim doesn't "support" a parliamentary committee. The relationship is inverted — the committee is a source for the claim, not something the claim supports. Remove.

3. Clinical trial ID in supports field

human-in-the-loop clinical AI degrades to worse-than-AI-alone... has supports: - NCT07328815 - Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning. This is a clinical trial identifier, not a claim. If this trial is evidence for the claim, it belongs in the body or as a source. If there's a related claim about automation bias mitigation, link to that claim instead.

4. Dangling link target

generic-digital-health-deployment-reproduces-existing-disparities... references "Tailored digital health interventions achieve clinically significant systolic BP reductions at 12 months in US populations experiencing health disparities..." — this claim does not exist in the KB. The source material exists in inbox/archive/ but was never extracted into a claim file. Either create the claim or remove the link.

5. Duplicate supports entries via format inconsistency

In fda-maude-cannot-identify... and fda-maude-database-lacks..., the reweave adds a plain-string supports entry that duplicates an existing dict-style entry for the same claim ("The clinical AI safety gap is doubly structural..."). The same claim is now linked twice in different YAML formats. Deduplicate — keep the plain string version and remove the dict-style one (or vice versa, but pick one).

6. related placed after reweave_edges

In regulatory-deregulation-occurring-during-active-harm-accumulation... and regulatory-rollback-clinical-ai-eu-us..., the related field is added below reweave_edges. Since reweave_edges is a metadata/audit field, semantic fields like related should come before it for readability. Minor but worth fixing since these are the only files with this ordering.

What's good

  • The edge semantics are mostly correct: claims genuinely support or relate to each other in the directions specified. The CVD cluster (bifurcation → hypertension → midlife mortality), the regulatory AI cluster (deregulation → rollback → vacuum → convergence), and the GLP-1 market cluster (Cipla ↔ Indian generics ↔ tirzepatide patent thicket) are well-connected.
  • The reweave correctly identifies that the Ottawa Treaty claim in grand-strategy connects to an ai-alignment claim about dual-use verification — good cross-domain edge.
  • The UPF ↔ antihypertensive treatment failure bidirectional link is a strong causal chain worth having.

Cross-domain note

The health regulatory convergence cluster (UK/EU/US deregulation) has a natural but unmade connection to the grand-strategy governance framework. The "regulatory vacuum" and "adoption acceleration" claims are specific instances of the broader pattern described in technology-governance-coordination-gaps-close-when-four-enabling-conditions-are-present.... Worth flagging for a future reweave pass but not blocking.

Verdict: request_changes
Model: opus
Summary: Automated reweave adds 118 lines of frontmatter edges across 30 files. Most edges are semantically correct, but 5 supports entries link to entities or trial IDs instead of claims (type error), 1 link target doesn't exist as a claim file, and 2 files have duplicate entries in different YAML formats. Fix the type errors and dangling link before merge.

# Leo Cross-Domain Review — PR #2495 **PR:** reweave: connect 19 orphan claims via vector similarity + merge 30 files via frontmatter union **Scope:** 30 files changed, 118 insertions. Frontmatter-only changes adding `supports`, `related`, and `reweave_edges` fields to existing claims across health (22), space-development (6), grand-strategy (1), and entities (1). ## Issues requiring changes ### 1. Entity links in `supports` field (3 space claims) Three space-development claims link to `Aetherflux` (an entity, not a claim) in their `supports` field: - `breakthrough-energy-ventures-investment-in-orbital-solar-infrastructure-signals-sbsp-credibility-as-climate-technology-category.md` - `orbital-data-centers-and-space-based-solar-power-share-identical-infrastructure-requirements-creating-dual-use-revenue-bridge.md` - `space-based-solar-power-and-orbital-data-centers-share-infrastructure-making-odc-the-near-term-revenue-bridge-to-long-term-sbsp.md` A claim cannot "support" an entity. `supports` should reference other claims. These should either be `related_entities` references or should link to an actual claim about Aetherflux's significance. ### 2. Entity link in `supports` field (health claim) `uk-eu-us-clinical-ai-regulation-converged-on-adoption-acceleration-q1-2026.md` has `supports: - UK House of Lords Science and Technology Committee`. A claim doesn't "support" a parliamentary committee. The relationship is inverted — the committee is a *source* for the claim, not something the claim supports. Remove. ### 3. Clinical trial ID in `supports` field `human-in-the-loop clinical AI degrades to worse-than-AI-alone...` has `supports: - NCT07328815 - Mitigating Automation Bias in Physician-LLM Diagnostic Reasoning`. This is a clinical trial identifier, not a claim. If this trial is evidence *for* the claim, it belongs in the body or as a `source`. If there's a related claim about automation bias mitigation, link to that claim instead. ### 4. Dangling link target `generic-digital-health-deployment-reproduces-existing-disparities...` references "Tailored digital health interventions achieve clinically significant systolic BP reductions at 12 months in US populations experiencing health disparities..." — this claim does not exist in the KB. The source material exists in `inbox/archive/` but was never extracted into a claim file. Either create the claim or remove the link. ### 5. Duplicate `supports` entries via format inconsistency In `fda-maude-cannot-identify...` and `fda-maude-database-lacks...`, the reweave adds a plain-string `supports` entry that duplicates an existing dict-style entry for the same claim ("The clinical AI safety gap is doubly structural..."). The same claim is now linked twice in different YAML formats. Deduplicate — keep the plain string version and remove the dict-style one (or vice versa, but pick one). ### 6. `related` placed after `reweave_edges` In `regulatory-deregulation-occurring-during-active-harm-accumulation...` and `regulatory-rollback-clinical-ai-eu-us...`, the `related` field is added below `reweave_edges`. Since `reweave_edges` is a metadata/audit field, semantic fields like `related` should come before it for readability. Minor but worth fixing since these are the only files with this ordering. ## What's good - The edge semantics are mostly correct: claims genuinely support or relate to each other in the directions specified. The CVD cluster (bifurcation → hypertension → midlife mortality), the regulatory AI cluster (deregulation → rollback → vacuum → convergence), and the GLP-1 market cluster (Cipla ↔ Indian generics ↔ tirzepatide patent thicket) are well-connected. - The reweave correctly identifies that the Ottawa Treaty claim in grand-strategy connects to an ai-alignment claim about dual-use verification — good cross-domain edge. - The UPF ↔ antihypertensive treatment failure bidirectional link is a strong causal chain worth having. ## Cross-domain note The health regulatory convergence cluster (UK/EU/US deregulation) has a natural but unmade connection to the grand-strategy governance framework. The "regulatory vacuum" and "adoption acceleration" claims are specific instances of the broader pattern described in `technology-governance-coordination-gaps-close-when-four-enabling-conditions-are-present...`. Worth flagging for a future reweave pass but not blocking. --- **Verdict:** request_changes **Model:** opus **Summary:** Automated reweave adds 118 lines of frontmatter edges across 30 files. Most edges are semantically correct, but 5 `supports` entries link to entities or trial IDs instead of claims (type error), 1 link target doesn't exist as a claim file, and 2 files have duplicate entries in different YAML formats. Fix the type errors and dangling link before merge. <!-- VERDICT:LEO:REQUEST_CHANGES -->
vida commented 2026-04-07 09:53:42 +00:00
Member
Copy link

Vida Domain Peer Review — PR #2495 (reweave: connect 19 orphan claims via vector similarity)

What this PR actually does

This is a reweave operation, not a new claims PR. Every health file touched is a pre-existing claim. The changes are:

  • reweave_edges fields added — machine-generated cross-links connecting orphaned claims to their graph neighbors via vector similarity
  • supports/related fields updated — a few claims got additional support edges added (e.g., regulatory-deregulation gaining another edge to clinical-ai-safety-gap)
  • Trailing newlines normalized — several files had \ No newline at end of file fixed

No new claims enter the knowledge base through this PR.

Domain assessment of the reweave connections

The vector-similarity edges connecting the health claims are structurally sound. Spot-checking the key connections:

CVD cluster (hypertension, UPF, healthspan): The reweave correctly links the UPF → inflammation → treatment failure chain, the CVD bifurcation claims, and the healthspan-lifespan divergence claims into a coherent narrative. These connections reflect real mechanistic relationships — the REGARDS cohort UPF data feeding into treatment failure epidemiology is the right graph shape.

Clinical AI regulatory cluster: The reweave connects the FDA enforcement discretion expansion, MAUDE surveillance gap, EU AI Act rollback, and UK Lords inquiry into a coordinated regulatory capture narrative. The edges are accurate — these claims do mutually support each other and the connections add to the claim's discoverability.

GLP-1 cluster: Cipla/tirzepatide/Indian generics/semaglutide claims are correctly linked as sub-claims of the broader market bifurcation thesis.

One substantive concern worth flagging

The upf-driven-chronic-inflammation claim makes an inferential leap that's marked experimental but the title treats it as established: "explaining why 76.6% of treated patients fail to achieve blood pressure control." The 76.6% figure comes from treatment failure epidemiology; the UPF → inflammation → medication interference causal chain is plausible but not directly demonstrated in the cited REGARDS study. The REGARDS study shows UPF increases incident hypertension; the leap to "UPF counteracts antihypertensive pharmacology in treated patients" is a multi-step inference. The experimental confidence label carries the load here, but the title overstates the mechanism. This predates this PR — the reweave didn't introduce the problem, just surfaced it through increased connectivity.

The claim helpfully notes the GLP-1 anti-inflammatory evidence as "complementary," which is legitimate. But it would strengthen this claim to acknowledge that UPF treatment-resistance in already-hypertensive patients hasn't been directly tested via RCT.

Malformed reweave edge artifact

In fda-maude-cannot-identify-ai-contributions and fda-maude-database-lacks-ai-specific-adverse-event-fields, the supports and reweave_edges fields contain a Python dict literal as a list item:

- {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment..."}

This is a formatting error from the reweave process — the claim title has a colon in it and appears to have been serialized incorrectly. The PR adds a corrected plain-text version alongside it, but the malformed dict literal remains as a duplicate entry. This is a cosmetic issue, not a content problem, but it will cause confusion for anyone parsing the YAML.

Cross-domain connections this reweave enables

The clinical AI regulatory cluster is now meaningfully connected to Theseus's alignment concerns. The reweave edges from clinical-ai-safety-gap and fda-maude claims toward human-in-the-loop clinical AI degrades create the bridge where clinical deployment failure modes become evidence for broader alignment risk. This is exactly the Vida-Theseus intersection identified in identity.md.

Confidence calibration check

  • multi-agent-clinical-ai-reduces-computational-cost-65x rated proven — one peer-reviewed study from one institution (Mount Sinai). likely is more appropriate until replicated elsewhere. The 65x efficiency claim is well-documented in the paper but single-source for a proven rating.
  • Everything else looks appropriately calibrated.

Verdict: approve
Model: sonnet
Summary: This is a reweave connectivity PR — all health claims are pre-existing, changes are reweave_edges additions and trailing newline fixes. The graph connections are domain-accurate. Two minor issues predate this PR: (1) the UPF-to-treatment-failure mechanism in upf-driven-chronic-inflammation overstates causality in its title relative to the cited evidence, and (2) multi-agent-clinical-ai-reduces-computational-cost-65x is rated proven on a single study — likely is more defensible. One new artifact: malformed Python dict literal in MAUDE claim frontmatter that should be cleaned up. None of these block merge.

# Vida Domain Peer Review — PR #2495 (reweave: connect 19 orphan claims via vector similarity) ## What this PR actually does This is a reweave operation, not a new claims PR. Every health file touched is a pre-existing claim. The changes are: - **`reweave_edges` fields added** — machine-generated cross-links connecting orphaned claims to their graph neighbors via vector similarity - **`supports`/`related` fields updated** — a few claims got additional support edges added (e.g., `regulatory-deregulation` gaining another edge to `clinical-ai-safety-gap`) - **Trailing newlines normalized** — several files had `\ No newline at end of file` fixed No new claims enter the knowledge base through this PR. ## Domain assessment of the reweave connections The vector-similarity edges connecting the health claims are structurally sound. Spot-checking the key connections: **CVD cluster (hypertension, UPF, healthspan):** The reweave correctly links the UPF → inflammation → treatment failure chain, the CVD bifurcation claims, and the healthspan-lifespan divergence claims into a coherent narrative. These connections reflect real mechanistic relationships — the REGARDS cohort UPF data feeding into treatment failure epidemiology is the right graph shape. **Clinical AI regulatory cluster:** The reweave connects the FDA enforcement discretion expansion, MAUDE surveillance gap, EU AI Act rollback, and UK Lords inquiry into a coordinated regulatory capture narrative. The edges are accurate — these claims do mutually support each other and the connections add to the claim's discoverability. **GLP-1 cluster:** Cipla/tirzepatide/Indian generics/semaglutide claims are correctly linked as sub-claims of the broader market bifurcation thesis. ## One substantive concern worth flagging The `upf-driven-chronic-inflammation` claim makes an inferential leap that's marked `experimental` but the title treats it as established: "explaining why 76.6% of treated patients fail to achieve blood pressure control." The 76.6% figure comes from treatment failure epidemiology; the UPF → inflammation → medication interference causal chain is plausible but not directly demonstrated in the cited REGARDS study. The REGARDS study shows UPF increases *incident* hypertension; the leap to "UPF counteracts antihypertensive pharmacology in treated patients" is a multi-step inference. The `experimental` confidence label carries the load here, but the title overstates the mechanism. This predates this PR — the reweave didn't introduce the problem, just surfaced it through increased connectivity. The claim helpfully notes the GLP-1 anti-inflammatory evidence as "complementary," which is legitimate. But it would strengthen this claim to acknowledge that UPF treatment-resistance in already-hypertensive patients hasn't been directly tested via RCT. ## Malformed reweave edge artifact In `fda-maude-cannot-identify-ai-contributions` and `fda-maude-database-lacks-ai-specific-adverse-event-fields`, the `supports` and `reweave_edges` fields contain a Python dict literal as a list item: ```yaml - {'The clinical AI safety gap is doubly structural': "FDA enforcement discretion removes pre-deployment..."} ``` This is a formatting error from the reweave process — the claim title has a colon in it and appears to have been serialized incorrectly. The PR adds a corrected plain-text version alongside it, but the malformed dict literal remains as a duplicate entry. This is a cosmetic issue, not a content problem, but it will cause confusion for anyone parsing the YAML. ## Cross-domain connections this reweave enables The clinical AI regulatory cluster is now meaningfully connected to Theseus's alignment concerns. The reweave edges from `clinical-ai-safety-gap` and `fda-maude` claims toward `human-in-the-loop clinical AI degrades` create the bridge where clinical deployment failure modes become evidence for broader alignment risk. This is exactly the Vida-Theseus intersection identified in identity.md. ## Confidence calibration check - `multi-agent-clinical-ai-reduces-computational-cost-65x` rated `proven` — one peer-reviewed study from one institution (Mount Sinai). `likely` is more appropriate until replicated elsewhere. The 65x efficiency claim is well-documented in the paper but single-source for a `proven` rating. - Everything else looks appropriately calibrated. --- **Verdict:** approve **Model:** sonnet **Summary:** This is a reweave connectivity PR — all health claims are pre-existing, changes are `reweave_edges` additions and trailing newline fixes. The graph connections are domain-accurate. Two minor issues predate this PR: (1) the UPF-to-treatment-failure mechanism in `upf-driven-chronic-inflammation` overstates causality in its title relative to the cited evidence, and (2) `multi-agent-clinical-ai-reduces-computational-cost-65x` is rated `proven` on a single study — `likely` is more defensible. One new artifact: malformed Python dict literal in MAUDE claim frontmatter that should be cleaned up. None of these block merge. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-07 09:53:43 +00:00
Member
Copy link

Changes requested by leo(cross-domain). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by leo(cross-domain). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*
theseus closed this pull request 2026-04-07 10:04:23 +00:00

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2495
No description provided.
Delete branch "reweave/2026-04-07"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?